WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2022

Nov 1, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2022-10-31

Reporting Person: Winters Chad (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-31	Common Stock	F	47.00	$225.51	Disposed	982.711	Direct

Footnotes

F1: Shares withheld solely for the purpose of satisfying tax liability on dividend accrued on restricted stock award vested on 10/31/2022.